.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
US Department of Justice
Moodys
Fuji
Citi
Deloitte
McKesson
Novartis
Cantor Fitzgerald

Generated: November 19, 2017

DrugPatentWatch Database Preview

Zolmitriptan - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for zolmitriptan and what is the scope of zolmitriptan freedom to operate?

Zolmitriptan
is the generic ingredient in three branded drugs marketed by Aurobindo Pharma Ltd, Astrazeneca, Alembic Pharms Ltd, Macleods Pharms Ltd, Ajanta Pharma Ltd, Jubilant Generics, Glenmark Generics, Teva Pharms Usa, Pld Acquisitions Llc, IPR, Appco Pharma Llc, Apotex Inc, Sun Pharma Global, Invagen Pharms, Mylan Pharms Inc, and Zydus Pharms Usa Inc, and is included in twenty-two NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for zolmitriptan. Twenty suppliers are listed for this compound.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa
ZOLMITRIPTAN
zolmitriptan
TABLET;ORAL090861-001Mar 4, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Astrazeneca
ZOMIG
zolmitriptan
SPRAY;NASAL021450-003Sep 16, 2013RXYesNo► Subscribe► SubscribeY► Subscribe
Astrazeneca
ZOMIG-ZMT
zolmitriptan
TABLET, ORALLY DISINTEGRATING;ORAL021231-002Sep 17, 2001ABRXYesYes► Subscribe► Subscribe► Subscribe
Jubilant Generics
ZOLMITRIPTAN
zolmitriptan
TABLET;ORAL202279-002Nov 20, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Invagen Pharms
ZOLMITRIPTAN
zolmitriptan
TABLET;ORAL204284-001Apr 9, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Jubilant Generics
ZOLMITRIPTAN
zolmitriptan
TABLET;ORAL202279-001Nov 20, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Jubilant Generics
ZOLMITRIPTAN
zolmitriptan
TABLET, ORALLY DISINTEGRATING;ORAL202956-002Sep 17, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Pld Acquisitions Llc
ZOLMITRIPTAN
zolmitriptan
TABLET;ORAL207867-002Feb 27, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Generics
ZOLMITRIPTAN
zolmitriptan
TABLET, ORALLY DISINTEGRATING;ORAL202560-001May 14, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Macleods Pharms Ltd
ZOLMITRIPTAN
zolmitriptan
TABLET;ORAL203772-001Sep 30, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: zolmitriptan

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ipr
ZOMIG
zolmitriptan
TABLET;ORAL020768-001Nov 25, 1997► Subscribe► Subscribe
Astrazeneca
ZOMIG-ZMT
zolmitriptan
TABLET, ORALLY DISINTEGRATING;ORAL021231-001Feb 13, 2001► Subscribe► Subscribe
Ipr
ZOMIG
zolmitriptan
TABLET;ORAL020768-001Nov 25, 1997► Subscribe► Subscribe
Astrazeneca
ZOMIG
zolmitriptan
SPRAY;NASAL021450-004Sep 30, 2003► Subscribe► Subscribe
Ipr
ZOMIG
zolmitriptan
TABLET;ORAL020768-002Nov 25, 1997► Subscribe► Subscribe
Astrazeneca
ZOMIG-ZMT
zolmitriptan
TABLET, ORALLY DISINTEGRATING;ORAL021231-002Sep 17, 2001► Subscribe► Subscribe
Ipr
ZOMIG
zolmitriptan
TABLET;ORAL020768-002Nov 25, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
US Department of Justice
Moodys
Citi
Chubb
Colorcon
Chinese Patent Office
Fish and Richardson
Express Scripts
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot